These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 8170984)
1. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Wiseman RW; Cochran C; Dietrich W; Lander ES; Söderkvist P Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3759-63. PubMed ID: 8170984 [TBL] [Abstract][Full Text] [Related]
2. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131 [TBL] [Abstract][Full Text] [Related]
3. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice. Zhuang SM; Wiseman RW; Söderkvist P Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863 [TBL] [Abstract][Full Text] [Related]
4. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Hegi ME; Söderkvist P; Foley JF; Schoonhoven R; Swenberg JA; Kari F; Maronpot R; Anderson MW; Wiseman RW Carcinogenesis; 1993 May; 14(5):803-10. PubMed ID: 8504472 [TBL] [Abstract][Full Text] [Related]
5. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Hegi ME; Devereux TR; Dietrich WF; Cochran CJ; Lander ES; Foley JF; Maronpot RR; Anderson MW; Wiseman RW Cancer Res; 1994 Dec; 54(23):6257-64. PubMed ID: 7954475 [TBL] [Abstract][Full Text] [Related]
6. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Herzog CR; Wang Y; You M Oncogene; 1995 Nov; 11(9):1811-5. PubMed ID: 7478609 [TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Herzog CR; Wiseman RW; You M Cancer Res; 1994 Aug; 54(15):4007-10. PubMed ID: 8033131 [TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Herzog CR; Chen B; Wang Y; Schut HA; You M Mol Carcinog; 1996 Jun; 16(2):83-90. PubMed ID: 8645430 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Ritland SR; Rowse GJ; Chang Y; Gendler SJ Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023 [TBL] [Abstract][Full Text] [Related]
11. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice. Cool M; Jolicoeur P Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755 [TBL] [Abstract][Full Text] [Related]
12. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
13. Oncogenes and tumor-suppressor genes. Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Hulla JE; French JE; Dunnick JK Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746 [TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Zhuang S; Söderkvist P Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886 [TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter. Xian J; Aitchison A; Bobrow L; Corbett G; Pannell R; Rabbitts T; Rabbitts P Cancer Res; 2004 Sep; 64(18):6432-7. PubMed ID: 15374951 [TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Davis LM; Caspary WJ; Sakallah SA; Maronpot R; Wiseman R; Barrett JC; Elliott R; Hozier JC Carcinogenesis; 1994 Aug; 15(8):1637-45. PubMed ID: 8055644 [TBL] [Abstract][Full Text] [Related]
19. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Haag JD; Hsu LC; Newton MA; Gould MN Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]